产品标题 产品货号 产品规格 厂家
Tumor necrosis factor receptor superfamily, member 6b, decoy (TNFRSF6B), transcript variant M68E from ORIGENE TECHNOLOGIESLY418407100 ugORIGENE TECHNOLOGIES
Tumor necrosis factor receptor superfamily, member 6b, decoy (TNFRSF6B), transcript variant M68E from ORIGENE TECHNOLOGIESLY429165100 ugORIGENE TECHNOLOGIES
Tumor necrosis factor receptor superfamily, member 11b (TNFRSF11B) from ORIGENE TECHNOLOGIESLY419252100 ugORIGENE TECHNOLOGIES
Tumor necrosis factor receptor superfamily, member 13B (TNFRSF13B) from ORIGENE TECHNOLOGIESLY402216100 ugORIGENE TECHNOLOGIES
Tumor necrosis factor receptor superfamily, member 1B (TNFRSF1B) from ORIGENE TECHNOLOGIESLY400436100 ugORIGENE TECHNOLOGIES
Tumor necrosis factor receptor superfamily, member 10b (TNFRSF10B), transcript variant 1 from ORIGENE TECHNOLOGIESLY401260100 ugORIGENE TECHNOLOGIES
Tumor necrosis factor receptor superfamily, member 10b (TNFRSF10B), transcript variant 2 from ORIGENE TECHNOLOGIESLY407781100 ugORIGENE TECHNOLOGIES
Tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain (TNFRSF10D) from ORIGENE TECHNOLOGIESLY401258100 ugORIGENE TECHNOLOGIES
Tumor necrosis factor receptor superfamily, member 13C (TNFRSF13C) from ORIGENE TECHNOLOGIESLY409380100 ugORIGENE TECHNOLOGIES
Tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) (TNFRSF14) from ORIGENE TECHNOLOGIESLY401254100 ugORIGENE TECHNOLOGIES
Tumor necrosis factor receptor superfamily, member 21 (TNFRSF21) from ORIGENE TECHNOLOGIESLY402336100 ugORIGENE TECHNOLOGIES
Tumor necrosis factor receptor superfamily, member 17 (TNFRSF17) from ORIGENE TECHNOLOGIESLY400483100 ugORIGENE TECHNOLOGIES
Human Breast; Gynecomastia from ORIGENE TECHNOLOGIESCS6174825x5umORIGENE TECHNOLOGIES
Human Breast; Gynecomastia from ORIGENE TECHNOLOGIESCS6174865x5umORIGENE TECHNOLOGIES
Human Breast; Gynecomastia from ORIGENE TECHNOLOGIESCS6174855x5umORIGENE TECHNOLOGIES
Human Breast; Gynecomastia from ORIGENE TECHNOLOGIESCS6174875x5umORIGENE TECHNOLOGIES
Human Breast; Gynecomastia from ORIGENE TECHNOLOGIESCS6220685x5umORIGENE TECHNOLOGIES
Human Breast; Gynecomastia from ORIGENE TECHNOLOGIESCS6220695x5umORIGENE TECHNOLOGIES
Human Breast; Gynecomastia from ORIGENE TECHNOLOGIESCS6220715x5umORIGENE TECHNOLOGIES
Human Breast; Gynecomastia from ORIGENE TECHNOLOGIESCS6220725x5umORIGENE TECHNOLOGIES
Human Breast; Gynecomastia from ORIGENE TECHNOLOGIESCS6220735x5umORIGENE TECHNOLOGIES
Human Breast; Gynecomastia from ORIGENE TECHNOLOGIESCS6273455x5umORIGENE TECHNOLOGIES
Human Breast; Lactational changes of breast from ORIGENE TECHNOLOGIESCS8081535x5umORIGENE TECHNOLOGIES
Human Breast; Lactational changes of breast from ORIGENE TECHNOLOGIESCS8081545x5umORIGENE TECHNOLOGIES
Human Breast; Lactational changes of breast from ORIGENE TECHNOLOGIESCS6293645x5umORIGENE TECHNOLOGIES
Human Breast; Lactational changes of breast from ORIGENE TECHNOLOGIESCS6293655x5umORIGENE TECHNOLOGIES
Human Breast; Lactational changes of breast from ORIGENE TECHNOLOGIESCS6293675x5umORIGENE TECHNOLOGIES
Human Breast; Lactational changes of breast from ORIGENE TECHNOLOGIESCS6293685x5umORIGENE TECHNOLOGIES
Human Breast; Lactational changes of breast from ORIGENE TECHNOLOGIESCS6293695x5umORIGENE TECHNOLOGIES
Human Breast, left; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS7160335x5umORIGENE TECHNOLOGIES
Human Breast, left; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS8144045x5umORIGENE TECHNOLOGIES
Human Breast, left; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS5257215x5umORIGENE TECHNOLOGIES
Human Breast, left; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS5492795x5umORIGENE TECHNOLOGIES
Human Breast, left; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS5513245x5umORIGENE TECHNOLOGIES
Human Breast, left; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS5526745x5umORIGENE TECHNOLOGIES
Human Breast, left; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS5528985x5umORIGENE TECHNOLOGIES
Human Breast, left; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS6518965x5umORIGENE TECHNOLOGIES
AHSA1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4017821 kitORIGENE TECHNOLOGIES
AHSA2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4134901 kitORIGENE TECHNOLOGIES
Ahsa1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5010141 kitORIGENE TECHNOLOGIES
Ahsa2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5010151 kitORIGENE TECHNOLOGIES
AHSA1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30178210 ugORIGENE TECHNOLOGIES
AHSA2 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH31349010 ugORIGENE TECHNOLOGIES
AHSG - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4083441 kitORIGENE TECHNOLOGIES
Ahsg - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5010161 kitORIGENE TECHNOLOGIES
AHSG Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30834410 ugORIGENE TECHNOLOGIES
AHSP - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4077431 kitORIGENE TECHNOLOGIES
Ahsp - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5010171 kitORIGENE TECHNOLOGIES
AHSP Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30774310 ugORIGENE TECHNOLOGIES
AICDA - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4029491 kitORIGENE TECHNOLOGIES
 |< < 2242 2243 2244 2245 2246 2247 2248 2249 2250 > >| 第 2248/6274 页